Stocks and Investing Stocks and Investing
Wed, November 1, 2023
[ 12:00 AM ] - WOPRAI
Scott Buck Maintained (TRNS) at Strong Buy with Increased Target to $108 on, Nov 1st, 2023
[ 12:00 AM ] - WOPRAI
Clarke Jeffries Maintained (TRMB) at Hold with Decreased Target to $42 on, Nov 1st, 2023
[ 12:00 AM ] - WOPRAI
Christopher Moore Upgraded (TNC) to Buy and Held Target at $100 on, Nov 1st, 2023
[ 12:00 AM ] - WOPRAI
John Ransom Maintained (THC) at Strong Buy with Decreased Target to $90 on, Nov 1st, 2023
[ 12:00 AM ] - WOPRAI
Eric Joseph Maintained (TGTX) at Buy with Increased Target to $23 on, Nov 1st, 2023
[ 12:00 AM ] - WOPRAI
Matthew Andrews Maintained (TGTX) at Strong Buy on, Nov 1st, 2023
[ 12:00 AM ] - WOPRAI
Mayank Tandon Maintained (TREE) at Strong Buy with Decreased Target to $17 on, Nov 1st, 2023
[ 12:00 AM ] - WOPRAI
James Friedman Maintained (TREE) at Hold with Decreased Target to $15 on, Nov 1st, 2023
[ 12:00 AM ] - WOPRAI
Youssef Squali Maintained (TREE) at Strong Buy with Decreased Target to $24 on, Nov 1st, 2023
Tue, October 31, 2023
[ 12:00 AM ] - WOPRAI
Jeff Cantwell Initiated (TOST) at Sell and Held Target at $16 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Ben Hendrix Maintained (THC) at Buy with Decreased Target to $72 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Ann Hynes Maintained (THC) at Strong Buy with Decreased Target to $77 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Ketan Mamtora Maintained (TREX) at Hold with Increased Target to $72 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Reuben Garner Reiterated (TREX) at Strong Buy and Held Target at $85 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Yatin Suneja Initiated (trml) at Strong Buy and Held Target at $50 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Chris Allen Upgraded (TROW) to Hold and Decreased Target to $95 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (TRU) at Hold with Decreased Target to $63 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Edward Kelly Maintained (SYY) at Buy and Held Target at $80 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Jake Bartlett Maintained (SYY) at Strong Buy and Held Target at $87 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Dana Telsey Reiterated (TDUP) at Buy and Held Target at $4 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Matthew McKellar Downgraded (CLW) to Hold on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Maintained (CHGG) at Hold with Decreased Target to $9 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Jeffrey Silber Maintained (CHGG) at Hold with Decreased Target to $10 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Eric Sheridan Maintained (CHGG) at Hold with Decreased Target to $10 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Doug Anmuth Maintained (CHGG) at Hold with Decreased Target to $10 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Eric Serotta Initiated (CELH) at Hold and Held Target at $63 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
David Feaster Maintained (CCB) at Strong Buy with Decreased Target to $53 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Duffy Fischer Maintained (CC) at Hold with Decreased Target to $30 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Gil Blum Maintained (SRPT) at Strong Buy with Decreased Target to $82 on, Oct 31st, 2023
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (SRPT) at Buy with Decreased Target to $146 on, Oct 31st, 2023

Matthew Harrison Maintained (SRPT) at Buy with Decreased Target to $146 on, Oct 31st, 2023


Published on 2024-10-28 07:13:41 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Decreased Target from $183 to $146 on, Oct 31st, 2023.

Matthew has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew

  • Uy Ear of "Mizuho" Reiterated at Strong Buy and Held Target at $160 on, Tuesday, September 26th, 2023
Contributing Sources